Hawaii 2024 Regular Session

Hawaii Senate Bill SB2316 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	THE SENATE S.B. NO. 2316 THIRTY-SECOND LEGISLATURE, 2024 STATE OF HAWAII A BILL FOR AN ACT relating to health insurance. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
2	2
3	3	THE SENATE S.B. NO. 2316
4	4	THIRTY-SECOND LEGISLATURE, 2024
5	5	STATE OF HAWAII
6	6
7	7	THE SENATE
8	8
9	9	S.B. NO.
10	10
11	11	2316
12	12
13	13	THIRTY-SECOND LEGISLATURE, 2024
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29
30	30
31	31	A BILL FOR AN ACT
32	32
33	33
34	34
35	35
36	36
37	37	relating to health insurance.
38	38
39	39
40	40
41	41
42	42
43	43	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
44	44
45	45
46	46
47	47	SECTION 1. The legislature finds that, according to the department of health, cancer is the second leading cause of death among Hawaii residents, claiming more than two thousand two hundred Hawaii residents each year. The legislature further finds that cancer patients should have full access to effective treatment options at early stages of their illnesses. The purpose of this Act is to prohibit health insurers that cover treatment for stage two through stage five cancer from requiring an insured diagnosed with stage two through stage five cancer to undergo step therapy prior to covering the insured for the drug prescribed by the insured's health care provider, under certain conditions. SECTION 2. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to part I of article 10A to be appropriately designated and to read as follows: "§431:10A- Step therapy prohibited; stage two through stage five cancer. (a) No individual accident and health or sickness policy issued or renewed in the State after December 31, 2024, that provides coverage for the treatment of stage two through stage five cancer shall require an insured who is diagnosed with a stage two through stage five cancer to undergo step therapy prior to covering the drug prescribed by the insured's health care provider if the prescribed drug is: (1) An investigational new drug; or (2) A prescription drug: (A) That is approved by the United States Food and Drug Administration; (B) Whose use is consistent with best practices for the treatment of the cancer in its respective stage; and (C) That is listed on the insurer's prescription drug formulary. (b) For the purposes of this section: "Investigational new drug" has the same meaning as provided under 21 Code of Federal Regulations section 312.3. "Step therapy" means a protocol that requires an insured to use a prescription drug or sequence of prescription drugs, other than the drug that the insured's health care provider recommends for the insured's treatment, before the insurer provides coverage for the recommended prescription drug." SECTION 3. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to part II of article 10A to be appropriately designated and to read as follows: "§431:10A- Step therapy prohibited; stage two through stage five cancer. (a) No group accident and health or sickness policy issued or renewed in the State after December 31, 2024, that provides coverage for the treatment of stage two through stage five cancer shall require an insured who is diagnosed with a stage two through stage five cancer to undergo step therapy prior to covering the drug prescribed by the insured's health care provider if the prescribed drug is: (1) An investigational new drug; or (2) A prescription drug: (A) That is approved by the United States Food and Drug Administration; (B) Whose use is consistent with best practices for the treatment of the cancer in its respective stage; and (C) That is listed on the insurer's prescription drug formulary. (b) For the purposes of this section: "Investigational new drug" has the same meaning as provided under 21 Code of Federal Regulations section 312.3. "Step therapy" means a protocol that requires an insured to use a prescription drug or sequence of prescription drugs, other than the drug that the insured's health care provider recommends for the insured's treatment, before the insurer provides coverage for the recommended prescription drug." SECTION 4. Chapter 432, Hawaii Revised Statutes, is amended by adding a new section to part VI of article 1 to be appropriately designated and to read as follows: "§432:1- Step therapy prohibited; stage two through stage five cancer. (a) No individual or group hospital or medical service plan contract issued or renewed in the State after December 31, 2024, that provides coverage for the treatment of stage two through stage five cancer shall require a subscriber or member who is diagnosed with a stage two through stage five cancer to undergo step therapy prior to covering the drug prescribed by the subscriber's or member's health care provider if the prescribed drug is: (1) An investigational new drug; or (2) A prescription drug: (A) That is approved by the United States Food and Drug Administration; (B) Whose use is consistent with best practices for the treatment of the cancer in its respective stage; and (C) That is listed on the mutual benefit society's prescription drug formulary. (b) For the purposes of this section: "Investigational new drug" has the same meaning as provided under 21 Code of Federal Regulations section 312.3. "Step therapy" means a protocol that requires a subscriber or member to use a prescription drug or sequence of prescription drugs, other than the drug that the subscriber's or member's health care provider recommends for the subscriber's or member's treatment, before the mutual benefit society provides coverage for the recommended prescription drug." SECTION 5. Chapter 432D, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows: "§432D- Step therapy prohibited; stage two through stage five cancer. (a) No policy, contract, plan, or agreement issued or renewed in the State after December 31, 2024, that provides coverage for the treatment of stage two through stage five cancer shall require an enrollee who is diagnosed with a stage two through stage five cancer to undergo step therapy prior to covering the drug prescribed by the enrollee's health care provider if the prescribed drug is: (1) An investigational new drug; or (2) A prescription drug: (A) That is approved by the United States Food and Drug Administration; (B) Whose use is consistent with best practices for the treatment of the cancer in its respective stage; and (C) That is listed on the health maintenance organization's prescription drug formulary. (b) For the purposes of this section: "Investigational new drug" has the same meaning as provided under 21 Code of Federal Regulations section 312.3. "Step therapy" means a protocol that requires an enrollee to use a prescription drug or sequence of prescription drugs, other than the drug that the enrollee's health care provider recommends for the enrollee's treatment, before the health maintenance organization provides coverage for the recommended prescription drug." SECTION 6. This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date. SECTION 7. New statutory material is underscored. SECTION 8. This Act shall take effect upon its approval. INTRODUCED BY: _____________________________
48	48
49	49	SECTION 1. The legislature finds that, according to the department of health, cancer is the second leading cause of death among Hawaii residents, claiming more than two thousand two hundred Hawaii residents each year. The legislature further finds that cancer patients should have full access to effective treatment options at early stages of their illnesses.
50	50
51	51	The purpose of this Act is to prohibit health insurers that cover treatment for stage two through stage five cancer from requiring an insured diagnosed with stage two through stage five cancer to undergo step therapy prior to covering the insured for the drug prescribed by the insured's health care provider, under certain conditions.
52	52
53	53	SECTION 2. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to part I of article 10A to be appropriately designated and to read as follows:
54	54
55	55	"§431:10A- Step therapy prohibited; stage two through stage five cancer. (a) No individual accident and health or sickness policy issued or renewed in the State after December 31, 2024, that provides coverage for the treatment of stage two through stage five cancer shall require an insured who is diagnosed with a stage two through stage five cancer to undergo step therapy prior to covering the drug prescribed by the insured's health care provider if the prescribed drug is:
56	56
57	57	(1) An investigational new drug; or
58	58
59	59	(2) A prescription drug:
60	60
61	61	(A) That is approved by the United States Food and Drug Administration;
62	62
63	63	(B) Whose use is consistent with best practices for the treatment of the cancer in its respective stage; and
64	64
65	65	(C) That is listed on the insurer's prescription drug formulary.
66	66
67	67	(b) For the purposes of this section:
68	68
69	69	"Investigational new drug" has the same meaning as provided under 21 Code of Federal Regulations section 312.3.
70	70
71	71	"Step therapy" means a protocol that requires an insured to use a prescription drug or sequence of prescription drugs, other than the drug that the insured's health care provider recommends for the insured's treatment, before the insurer provides coverage for the recommended prescription drug."
72	72
73	73	SECTION 3. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to part II of article 10A to be appropriately designated and to read as follows:
74	74
75	75	"§431:10A- Step therapy prohibited; stage two through stage five cancer. (a) No group accident and health or sickness policy issued or renewed in the State after December 31, 2024, that provides coverage for the treatment of stage two through stage five cancer shall require an insured who is diagnosed with a stage two through stage five cancer to undergo step therapy prior to covering the drug prescribed by the insured's health care provider if the prescribed drug is:
76	76
77	77	(1) An investigational new drug; or
78	78
79	79	(2) A prescription drug:
80	80
81	81	(A) That is approved by the United States Food and Drug Administration;
82	82
83	83	(B) Whose use is consistent with best practices for the treatment of the cancer in its respective stage; and
84	84
85	85	(C) That is listed on the insurer's prescription drug formulary.
86	86
87	87	(b) For the purposes of this section:
88	88
89	89	"Investigational new drug" has the same meaning as provided under 21 Code of Federal Regulations section 312.3.
90	90
91	91	"Step therapy" means a protocol that requires an insured to use a prescription drug or sequence of prescription drugs, other than the drug that the insured's health care provider recommends for the insured's treatment, before the insurer provides coverage for the recommended prescription drug."
92	92
93	93	SECTION 4. Chapter 432, Hawaii Revised Statutes, is amended by adding a new section to part VI of article 1 to be appropriately designated and to read as follows:
94	94
95	95	"§432:1- Step therapy prohibited; stage two through stage five cancer. (a) No individual or group hospital or medical service plan contract issued or renewed in the State after December 31, 2024, that provides coverage for the treatment of stage two through stage five cancer shall require a subscriber or member who is diagnosed with a stage two through stage five cancer to undergo step therapy prior to covering the drug prescribed by the subscriber's or member's health care provider if the prescribed drug is:
96	96
97	97	(1) An investigational new drug; or
98	98
99	99	(2) A prescription drug:
100	100
101	101	(A) That is approved by the United States Food and Drug Administration;
102	102
103	103	(B) Whose use is consistent with best practices for the treatment of the cancer in its respective stage; and
104	104
105	105	(C) That is listed on the mutual benefit society's prescription drug formulary.
106	106
107	107	(b) For the purposes of this section:
108	108
109	109	"Investigational new drug" has the same meaning as provided under 21 Code of Federal Regulations section 312.3.
110	110
111	111	"Step therapy" means a protocol that requires a subscriber or member to use a prescription drug or sequence of prescription drugs, other than the drug that the subscriber's or member's health care provider recommends for the subscriber's or member's treatment, before the mutual benefit society provides coverage for the recommended prescription drug."
112	112
113	113	SECTION 5. Chapter 432D, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:
114	114
115	115	"§432D- Step therapy prohibited; stage two through stage five cancer. (a) No policy, contract, plan, or agreement issued or renewed in the State after December 31, 2024, that provides coverage for the treatment of stage two through stage five cancer shall require an enrollee who is diagnosed with a stage two through stage five cancer to undergo step therapy prior to covering the drug prescribed by the enrollee's health care provider if the prescribed drug is:
116	116
117	117	(1) An investigational new drug; or
118	118
119	119	(2) A prescription drug:
120	120
121	121	(A) That is approved by the United States Food and Drug Administration;
122	122
123	123	(B) Whose use is consistent with best practices for the treatment of the cancer in its respective stage; and
124	124
125	125	(C) That is listed on the health maintenance organization's prescription drug formulary.
126	126
127	127	(b) For the purposes of this section:
128	128
129	129	"Investigational new drug" has the same meaning as provided under 21 Code of Federal Regulations section 312.3.
130	130
131	131	"Step therapy" means a protocol that requires an enrollee to use a prescription drug or sequence of prescription drugs, other than the drug that the enrollee's health care provider recommends for the enrollee's treatment, before the health maintenance organization provides coverage for the recommended prescription drug."
132	132
133	133	SECTION 6. This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.
134	134
135	135	SECTION 7. New statutory material is underscored.
136	136
137	137	SECTION 8. This Act shall take effect upon its approval.
138	138
139	139
140	140
141	141	INTRODUCED BY: _____________________________
142	142
143	143	INTRODUCED BY:
144	144
145	145	_____________________________
146	146
147	147
148	148
149	149
150	150
151	151	Report Title: Health Insurance; Step Therapy; Prohibition Description: Prohibits a health insurer from requiring an insured diagnosed with stage two through stage five cancer to undergo step therapy prior to covering the insured for certain drugs prescribed by the insured's health care provider, under certain conditions. The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
152	152
153	153
154	154
155	155
156	156
157	157
158	158
159	159	Report Title:
160	160
161	161	Health Insurance; Step Therapy; Prohibition
162	162
163	163
164	164
165	165	Description:
166	166
167	167	Prohibits a health insurer from requiring an insured diagnosed with stage two through stage five cancer to undergo step therapy prior to covering the insured for certain drugs prescribed by the insured's health care provider, under certain conditions.
168	168
169	169
170	170
171	171
172	172
173	173
174	174
175	175	The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.